Company Curable. Inc.

Equities

A086460

KR7086460003

Biotechnology & Medical Research

End-of-day quote Korea S.E. 23:00:00 23/05/2024 BST 5-day change 1st Jan Change
4,785 KRW -0.10% Intraday chart for Curable. Inc. +8.75% -27.17%

Business Summary

Curable Inc, SNP Genetics Inc, is a Korea-based company mainly engaged in the analysis of genomes. The company is involved in the research and development of disease-related single nucleotide polymorphism (SNP) contents using SNP. These diseases include asthma, diabetes, osteoporosis, alcoholism, tuberculosis, cancer, multiple sclerosis, obesity, mental illness, metabolic disease, lupus disease. The Company is involved in the production and sale of Kobreed kits, as well as the provision of SNP Care. The Kobreed kits are medicine for discriminating Korean beef and imported meat. SNP Care is a gene analysis service. In addition, the Company is engaged in leasing of the places of business. The major customers include government agencies such as the Disease Control Headquarters and the Food and Drug Administration.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Others
65.7 %
88 22.6 % 139 65.7 % +58.64%
Production of Samples for Research
34.3 %
300 77.4 % 73 34.3 % -75.79%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
387 100.0 % 212 100.0 % -45.35%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 25/05/00
Chief Tech/Sci/R&D Officer 47 21/02/16
Director/Board Member 79 -
Comptroller/Controller/Auditor 61 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 61 25/05/00
Director/Board Member 79 -
Chief Tech/Sci/R&D Officer 47 21/02/16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,939,400 692,437 ( 23.56 %) 17,669 ( 0.6011 %) 23.56 %

Company contact information

Curable, Inc.

1007 Sogang University Teilhard Hall 35 Baekbeom-ro

04107, Seoul

+

http://www.snp-genetics.com
address Curable. Inc.(A086460)